Antidepressant effect of methanol root bark extract of Acacia seyal Del. (Fabaceae): Possible involvement of the inflammatory pathway

被引:5
作者
Shehu, Aishatu [1 ]
Anyip, Bishio [1 ]
Magaji, Mohammed Garba [1 ]
机构
[1] Ahmadu Bello Univ, Dept Pharmacol & Therapeut, Zaria, Nigeria
关键词
Depression; Acacia seyal; Tail suspension test; Open field test; Bacillus Calmette-Guerin; CALMETTE-GUERIN; DEPRESSION; INOCULATION; MICE;
D O I
10.4314/tjpr.v19i7.18
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose: To study the involvement of inflammatory pathways in the antidepressant activity of Acacia seyal in mice. Methods: The median lethal dose (LD50) of the extract Acacia seyal (AS) was determined using OECD guideline 425. The antidepressant activity of AS was assessed against BCG (0.2 mg/kg, ip)-induced depression in mice using Tail suspension test (TST) and open field test (OFT) at 4, 24 and 48 hours post BCG administration. Results: The median lethal dose (LD50) for the extract was > 5000 mg/kg orally. The extract AS at all tested doses (250 - 1000 mg/kg) significantly (p <= 0.001) decreased the duration of immobility in TST but increased the number of line crossing in OFT post-BCG. Conclusion: The antidepressant activity of the methanol root bark extract of Acacia seyal in mice may involve an inflammatory mechanism. Thus, the extract of Acacia seyal may be suitable for the management of depression in humans resistant to other conventional antidepressant agents. However, further studies are required to ascertain this
引用
收藏
页码:1459 / 1464
页数:6
相关论文
共 26 条
  • [1] [Anonymous], BRAIN RES
  • [2] [Anonymous], 2008, 425 OECD, P1
  • [3] Potential for unintended consequences of environmental enrichment for laboratory animals and research results
    Bayne, K
    [J]. ILAR JOURNAL, 2005, 46 (02) : 129 - 139
  • [4] Cellular and molecular inflammatory profile of the choroid plexus in depression and suicide
    Devorak, Julia
    Torres-Platas, Susana Gabriela
    Davoli, Maria Antonietta
    Prud'homme, Josee
    Turecki, Gustavo
    Mechawar, Naguib
    [J]. FRONTIERS IN PSYCHIATRY, 2015, 6
  • [5] Elnour AAM, 2018, J PHARM PHARMACOTHER, V5, P1, DOI [10.21767/2393-8862.100012, DOI 10.21767/2393-8862.100012]
  • [6] Evelin P, 2012, BRIT J PHARMACOL, V170, P1014
  • [7] Treatment of anxiety and depression: medicinal plants in retrospect
    Fajemiroye, James O.
    da Silva, Dayane M.
    de Oliveira, Danillo R.
    Costa, Elson A.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2016, 30 (03) : 198 - 215
  • [8] Moving forward: how depression heterogeneity hinders progress in treatment and research
    Fried, E. I.
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2017, 17 (05) : 423 - 425
  • [9] The expression of genes encoding for COX-2, MPO, iNOS, and sPLA2-IIA in patients with recurrent depressive disorder
    Galecki, Piotr
    Galecka, Elzbieta
    Maes, Michael
    Chamielec, Marcelina
    Orzechowska, Agata
    Bobinska, Kinga
    Lewinski, Andrzej
    Szemraj, Janusz
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2012, 138 (03) : 360 - 366
  • [10] Visceral Inflammation and Immune Activation Stress the Brain
    Holzer, Peter
    Farzi, Aitak
    Hassan, Ahmed M.
    Zenz, Geraldine
    Jacan, Angela
    Reichmann, Florian
    [J]. FRONTIERS IN IMMUNOLOGY, 2017, 8